Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(18%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_3
3
27%
Ph phase_4
4
36%
Ph not_applicable
2
18%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Other(3)

Detailed Status

Completed6
unknown3
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 33 (30.0%)
Phase 44 (40.0%)
N/A2 (20.0%)

Trials by Status

recruiting19%
unknown327%
active_not_recruiting19%
completed655%

Recent Activity

2 active trials
Showing 5 of 11
completednot_applicable

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

NCT04451746
active_not_recruitingphase_3

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

NCT04333576
recruitingphase_4

Impact of Combined Oral Contraceptive Pills on Migraine

NCT06509503
unknownphase_4

Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome

NCT06083935
completedphase_3

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

NCT04537078
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04451746Not Applicable

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

Completed
NCT04333576Phase 3

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Active Not Recruiting
NCT06509503Phase 4

Impact of Combined Oral Contraceptive Pills on Migraine

Recruiting
NCT06083935Phase 4

Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome

Unknown
NCT04537078Phase 3

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

Completed
NCT05244811Phase 3

Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

Unknown
NCT02367833Phase 4

Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis

Completed
NCT03654144Phase 4

Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

Unknown
NCT03478020Phase 1

Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

Completed
NCT03383185

Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives

Completed
NCT02146248Not Applicable

HSG and Tubal Patency Study

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11